Learning Hub Central

Lymphoma

← Back to Specialities

2025 SPS Seattle | Hodgkin Lymphoma Front Line Efficacy and Toxicity Considerations

Lymphoma

1 Chapter

Non-CME Credit Course

2025 NOSCM | Follicular NHL: Novel Treatment Paradigms

Lymphoma

1 Chapter

Non-CME Credit Course

2025 NOSCM | Hodgkin’s Disease: Novel Advances in Early and Advanced Stages

Lymphoma

1 Chapter

Non-CME Credit Course

2025 NOSCM | The Complexity of Treatment Options for DLBCL: Novel Antibodies and CAR-T Cell Therapy

Lymphoma

1 Chapter

Non-CME Credit Course

2025 NOSCM | Novel Advances in T-Cell NHL Therapies

Lymphoma

1 Chapter

Non-CME Credit Course

2025 MLS Nashville | CLL/Lymphoma Updates

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | Navigating Mantle Cell Lymphoma in the Era of Targeted Therapy

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | Novel Advances in T-Cell NHL Therapies

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | What Is New for DLBCL and & Hodgkin’s Disease?

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MLS Nashville | CLL/Lymphoma Updates in 2024

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MCM | B-Cell NHL (Low-Grades)

Lymphoma

1 Chapter

Non-CME Credit Course

2024 PRIMO | Update on Novel Therapies for NHL

Lymphoma

1 Chapter

Non-CME Credit Course

Updates in Lymphomas

Lymphoma

1 Chapter

Non-CME Credit Course

2022 UCT | Modern Challenges and new options for B-cell NHL

Lymphoma

1 Chapter

Non-CME Credit Course

2022 UCT | Update on T-cell Lymphomas

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | Waldenstrom’s Macroglobulinemia

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | T-Cell NHL: Novel Approaches & Challenges

Lymphoma

1 Chapter

Non-CME Credit Course

Redefining Treatment Algorithms in B-cell Lymphomas: A Focus on CAR-T Cell TherapyLymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

Novel Therapeutic Advances for DLBCL & Hodgkin’s Disease

Lymphoma

1 Chapter

Non-CME Credit Course

Follicular Lymphoma: Defining Best 1L and 2L Treatment in the Era of Personalized Medicine

Lymphoma

1 Chapter

Non-CME Credit Course

Follicular Lymphoma and CLL Updates 2023

Lymphoma

1 Chapter

Non-CME Credit Course

Follicular, Marginal Zone and Mantle Cell NHL: Novel Advances

Lymphoma

1 Chapter

Non-CME Credit Course

DLBCL & Hodgkin’s Disease

Lymphoma

1 Chapter

Non-CME Credit Course

Lymphoma and CLL Update

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | CAR T Cell Therapies in Lymphoid Malignancies: Here to Stay!

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | New Approaches for Follicular Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2022 NOSCM | DLBCL & Hodgkin’s Disease: Novel Approaches

Lymphoma

1 Chapter

Non-CME Credit Course

Burkitt Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

Double Hit Lymphomas

Lymphoma

1 Chapter

Non-CME Credit Course

CNS Lymphomas

Lymphoma

1 Chapter

Non-CME Credit Course

Current Standard of Therapies in CLL

Lymphoma

1 Chapter

Non-CME Credit Course

New Therapies for Follicular Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

Marginal Zone Lymphomas

Lymphoma

1 Chapter

Non-CME Credit Course

DLBCL: Current Therapeutic Approaches

Lymphoma

1 Chapter

Non-CME Credit Course

PTCL: Evolving targeted therapies for mature T cell lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2022 MCM | B-Cell Lymphomas: Updates and Future Directions

Lymphoma

1 Chapter

Non-CME Credit Course

2022 AIO | Large B-cell Lymphoma: What to do now and what’s coming next

Lymphoma

1 Chapter

Non-CME Credit Course

2022 AIO | Lymphoma Data Science from Populations to Precision Medicine and Back

Lymphoma

1 Chapter

Non-CME Credit Course

2021 NOSCM | Follicular Lymphoma: Novel Advances and Pathways

Lymphoma

1 Chapter

Non-CME Credit Course

T-Cell NHL: What’s New?

Lymphoma

1 Chapter

Non-CME Credit Course

2021 UCT | Update from ASCO/AACR/ESMO in T-cell NHL

Lymphoma

1 Chapter

Non-CME Credit Course

2021 AIO | Optimal Therapeutic Strategies for non-Hodgkin lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

Updates in Treatment of Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

DLBCL: The Latest and Greatest

Lymphoma

1 Chapter

Non-CME Credit Course

T-Cell Lymphomas - New Therapeutic Approaches

Lymphoma

1 Chapter

Non-CME Credit Course

Peripheral T-Cell Lymphoma: Novel Agents & New Horizons

Lymphoma

1 Chapter

Non-CME Credit Course

Diffuse Large B-Cell Lymphoma: Updates and Future Directions

Lymphoma

1 Chapter

Non-CME Credit Course

Follicular Lymphoma: When to Start Therapy and How To Decide The Optimal Treatment?

Lymphoma

1 Chapter

Non-CME Credit Course

State of the Art in Early Hodgkin Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

B-Cell Lymphomas: New Therapeutic Approaches

Lymphoma

1 Chapter

Non-CME Credit Course

B-Cell Lymphomas including Hodgkin’s Disease

Lymphoma

1 Chapter

Non-CME Credit Course

2022 CCC | Lymphoma: State of the Art

Lymphoma

1 Chapter

Non-CME Credit Course

Changing the landscape of treatment in Peripheral T-cell Lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

Diffuse Large Cell Lymphoma - The Latest and Greatest

Lymphoma

1 Chapter

Non-CME Credit Course

Lymphoma and CLL 2024 Updates

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MCM | B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)

Lymphoma

1 Chapter

Non-CME Credit Course

2024 MCM | T-Cell NHL- Novel Therapies

Lymphoma

1 Chapter

Non-CME Credit Course

2022 AIO | State of the Art in non-Hodgkin lymphoma

Lymphoma

1 Chapter

Non-CME Credit Course

2024 NOSCM | CAR-T Cell Therapy in Lymphomas: 7-Years Later

Lymphoma

1 Chapter

Non-CME Credit Course

Contact Us

info@meccinc.com

(305) 663-1628